SEHK:2616
SEHK:2616Biotechs

EMA Backing for Sugemalimab Might Change the Case for Investing in CStone Pharmaceuticals (SEHK:2616)

Earlier this month, CStone Pharmaceuticals received a positive opinion from the European Medicines Agency's CHMP recommending approval of sugemalimab as a monotherapy for adults with unresectable stage III non-small cell lung cancer, following compelling Phase III data from the GEMSTONE-301 trial. This regulatory milestone further strengthens CStone’s clinical track record in oncology and highlights the company’s ability to advance immunotherapies addressing significant unmet needs in...
SEHK:1208
SEHK:1208Metals and Mining

MMG Limited (SEHK:1208): Evaluating Valuation Following Fresh Production Results and Updated Performance Metrics

MMG (SEHK:1208) has released its latest production results for the third quarter and year to date, giving investors an up-to-date look at output levels for copper, zinc, lead, and molybdenum. This fresh data can help gauge how the company is tracking against its operational goals and shapes expectations moving forward. See our latest analysis for MMG. The latest results come amid a surge in momentum for MMG, with a strong 79.4% 90-day share price return and an even more remarkable 187% gain...
SEHK:2477
SEHK:2477IT

A Look at WellCell Holdings (SEHK:2477) Valuation Following Its Latest Stablecoin-Powered Payments Launch

WellCell Holdings (SEHK:2477) just announced that Fopay is rolling out cross-border transfer and QR code payment features powered by stablecoin technology. This launch signals WellCell’s continued push to broaden its digital payments reach while keeping regulatory compliance in mind. See our latest analysis for WellCell Holdings. WellCell Holdings’ latest innovation comes at a time when market momentum is undeniable, with a 1-day share price return of 1.6% and an eye-popping 318%...
SEHK:1164
SEHK:1164Oil and Gas

CGN Mining (SEHK:1164): Assessing Valuation Following Q3 Operating Results and Uranium Production Update

CGN Mining (SEHK:1164) just reported its third quarter 2025 operating results, highlighting steady natural uranium production. The company’s previous quarter saw a 96.5% completion of its planned output, which kept operational performance on track. See our latest analysis for CGN Mining. Momentum clearly continues to build behind CGN Mining, with the share price jumping 3.07% in the latest session and surging 70.05% over the past 90 days. That enthusiasm reflects both steady operational...
SEHK:1519
SEHK:1519Logistics

How Investors Are Reacting To J&T Global Express (SEHK:1519) Surging Parcel Volumes and Double-Digit Growth

J&T Global Express Limited recently reported its operating results for the third quarter ended September 30, 2025, achieving a total parcel volume of approximately 7.68 billion, a 23.1% increase from the prior year, with all major markets experiencing double-digit growth, particularly in Southeast Asia and New Markets. The surge in parcel volumes highlights not only the strong momentum behind e-commerce in J&T’s core regions but also the company’s expanding footprint in emerging logistics...